Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Dehydroabiethylamine (NSC-2955) is an inducer of hepatic CYP2B activity. Dehydroabiethylamine inhibits pyruvate dehydrogenase kinases (PDKs) and intracellular cholesterol transport with anti-tumor activity.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
500 mg | 在庫あり | ¥ 9,000 | |||
1 g | 在庫あり | ¥ 13,000 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 9,000 |
説明 | Dehydroabiethylamine (NSC-2955) is an inducer of hepatic CYP2B activity. Dehydroabiethylamine inhibits pyruvate dehydrogenase kinases (PDKs) and intracellular cholesterol transport with anti-tumor activity. |
別名 | NSC-2955, NSC 2955, Dehydroabietylamine, NSC2955, Leelamine free base, Leelamine |
分子量 | 285.47 |
分子式 | C20H31N |
CAS No. | 1446-61-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 25 mg/mL (87.57 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Dehydroabiethylamine 1446-61-3 Metabolism PI3K/Akt/mTOR signaling P450 PDK Pyruvate dehydrogenase kinase PDH kinase Inhibitor PDHK NSC-2955 NSC 2955 Dehydroabietylamine NSC2955 Cannabinoid Receptor Leelamine free base Leelamine inhibit inhibitor